Does IDARUCIZUMAB Cause Rectal haemorrhage? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Rectal haemorrhage have been filed in association with IDARUCIZUMAB (Praxbind). This represents 1.0% of all adverse event reports for IDARUCIZUMAB.
16
Reports of Rectal haemorrhage with IDARUCIZUMAB
1.0%
of all IDARUCIZUMAB reports
11
Deaths
8
Hospitalizations
How Dangerous Is Rectal haemorrhage From IDARUCIZUMAB?
Of the 16 reports, 11 (68.8%) resulted in death, 8 (50.0%) required hospitalization, and 3 (18.8%) were considered life-threatening.
Is Rectal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDARUCIZUMAB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does IDARUCIZUMAB Cause?
Death (170)
Haemorrhage (110)
Cerebral haemorrhage (92)
Gastrointestinal haemorrhage (83)
Haemorrhage intracranial (68)
Multiple organ dysfunction syndrome (68)
Drug ineffective (58)
Pneumonia (51)
Acute kidney injury (49)
Cerebral infarction (46)
What Other Drugs Cause Rectal haemorrhage?
RIVAROXABAN (4,501)
ASPIRIN (3,057)
ADALIMUMAB (2,629)
VEDOLIZUMAB (2,163)
INFLIXIMAB (1,554)
CLOPIDOGREL BISULFATE (1,333)
APIXABAN (1,177)
WARFARIN (1,174)
PREDNISONE (1,098)
MESALAMINE (990)
Which IDARUCIZUMAB Alternatives Have Lower Rectal haemorrhage Risk?
IDARUCIZUMAB vs IDECABTAGENE VICLEUCEL
IDARUCIZUMAB vs IDELALISIB
IDARUCIZUMAB vs IDURSULFASE
IDARUCIZUMAB vs IFOSFAMIDE
IDARUCIZUMAB vs IGURATIMOD